These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2873471)

  • 1. Dopamine D2 receptors in schizophrenia studied in vivo.
    Crawley JC; Owens DG; Crow TJ; Poulter M; Johnstone EC; Smith T; Oldland SR; Veall N; Owen F; Zanelli GD
    Lancet; 1986 Jul; 2(8500):224-5. PubMed ID: 2873471
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain dopamine receptors in schizophrenia: PET problems.
    Seeman P
    Arch Gen Psychiatry; 1988 Jun; 45(6):598-600. PubMed ID: 3259865
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron tomography of a radio-brominated analog of the D1/DA1 antagonist, SCH 23390.
    Friedman AM; DeJesus OT; Woolverton WL; van Moffaert G; Goldberg LI; Prasad A; Barnett A; Dinerstein RJ
    Eur J Pharmacol; 1985 Feb; 108(3):327-8. PubMed ID: 3886409
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients.
    Sedvall G; Farde L; Wiesel FA
    Life Sci; 1987 Aug; 41(7):813-6. PubMed ID: 2956473
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 7. The preparation and use of [77Br]p-bromospiperone for clinical dopamine D2 receptor measurements.
    Oldland SR; Veall N
    Int J Rad Appl Instrum A; 1986; 37(8):715-7. PubMed ID: 3021672
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine D2 densities and the schizophrenic brain.
    Zakzanis KK; Hansen KT
    Schizophr Res; 1998 Aug; 32(3):201-6. PubMed ID: 9720125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine receptors in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1996 Jan; 347(8996):264. PubMed ID: 8551909
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiobrominated spiroperidol for the study of dopamine D2 receptors.
    De Jesus OT; Friedman AM
    Int J Rad Appl Instrum A; 1986; 37(8):719-26. PubMed ID: 3021673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of dopaminergic variables in schizophrenia.
    Martinot JL; Paillere-Martinot ML; Lecrubier Y; Dao-Castellana MH; Loc'h C; Poirier MF; Allilaire JF; Feline A; Manus A; Aubin F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():470A-471A. PubMed ID: 1354053
    [No Abstract]   [Full Text] [Related]  

  • 13. [Imaging of D2 dopamine receptor].
    Hatazawa J; Itoh M; Ido T
    Nihon Rinsho; 1991 Jul; 49(7):1546-50. PubMed ID: 1832197
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography.
    Shinotoh H; Aotsuka A; Inoue O; Suzuki K; Fukuda H; Iyo M; Yamazaki T; Tateno Y; Hirayama K; Nohara N
    Adv Exp Med Biol; 1991; 287():249-53. PubMed ID: 1836930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positron emission tomography studies of dopamine D1 receptors].
    Shinotoh H
    Nihon Rinsho; 1991 Jul; 49(7):1541-5. PubMed ID: 1832196
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
    Pearce RK; Seeman P; Jellinger K; Tourtellotte WW
    Eur Neurol; 1990; 30 Suppl 1():9-14. PubMed ID: 2138080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.
    Wong DF; Pearlson GD; Tune LE; Young LT; Meltzer CC; Dannals RF; Ravert HT; Reith J; Kuhar MJ; Gjedde A
    J Cereb Blood Flow Metab; 1997 Mar; 17(3):331-42. PubMed ID: 9119906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of radiobrominated p-bromospiroperidol for gamma-ray imaging of dopamine receptors.
    Friedman AM; Huang CC; Kulmala HA; Dinerstein R; Navone J; Brunsden B; Gawlas D; Cooper M
    Int J Nucl Med Biol; 1982; 9(1):57-61. PubMed ID: 6979525
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine receptors displayed in living human brain with 77Br-p-bromospiperone.
    Crawley JC; Smith T; Veall N; Zanelli GD; Crow TJ; Owen F
    Lancet; 1983 Oct; 2(8356):975. PubMed ID: 6138540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.